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Abstract
Background: Describe dual contraceptive method use and the intention to become pregnant of people living with
HIV (PLHIV) and their partners in Thailand.
Methods: From January 2008–March 2009, we systematically selected a cohort of PLHIV from PLHIV seeking care
at five tertiary care hospitals and one community hospital to complete a questionnaire assessing sexual activity,
intention to become pregnant, and contraceptive practices at baseline and 12 months after enrollment. Participants
received short family planning messages every 2–3 months to promote the use of dual contraceptives and were
offered family planning services.
Results: A total of 1,388 PLHIV enrolled, their median age was 37 years (IQR 33–43), 898 (64.7 %) had a steady
partner, and 737 (53.1 %) were male. Among those with a steady partner, 862 (96.0 %) did not intend to become
pregnant; 709 (82.3 %) had sex during the previous 3 months, 683 (96.3 %) used at least one contraceptive method,
and 202 (29.6 %) used dual contraceptive methods. Of the 317 PLHIV who used a single contraceptive method at
baseline, 66 (20.8 %) reported using dual methods at 12 months. Participants at two tertiary care hospitals where
coordinators facilitated PLHIV referral between HIV and OB/GYN clinics were more likely than participants at the
other hospitals to change from single method to dual method (p≤ 0.03).
Conclusion: Few PLHIV in this study intended to become pregnant; however, only one-fourth used dual
contraceptive methods. Integrating an assessment of the intention to become pregnant and strengthening the
PLHIV referral systems in family planning services may contribute to higher rates of dual contraceptive use.
Keywords: HIV infection, Pregnancy desire, Dual contraceptive use, Family planning, Thailand
Background
Approximately 450,000 adults were living with HIV/
AIDS in Thailand in 2013 [1] and more than half of
them were 18–49 years old. Thailand provides universal
access to antiretroviral treatment (ART) under the na-
tional AIDS program and ART use has increased life ex-
pectancy and improved the quality of life of people living
with HIV and AIDS (PLHIV) [2]. Longer life expectancy
and an improved quality of life may increase the number
of PLHIV who desire to become pregnant and have chil-
dren [3]. A study in Canada showed that the proportion of
HIV-infected women who desired children and intended
to become pregnant increased once they were receiving
ART [4].
Studies have shown that many PLHIV do not have
access to family planning services [5–9]. Women with
unintended pregnancies are more likely to have poor
pregnancy outcomes (e.g., abortions, preterm birth, low
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birth weight) than women who plan their pregnancies
[10]. HIV-infected women are also at risk of transmitting
HIV to their infants and sexual partners. Thus, providing
family planning services to PLHIV can improve the health
of HIV-infected women and their children and reduce the
risk of mother-to-child HIV transmission (MTCT).
The correct and consistent use of contraceptive
methods is important to prevent unintended pregnancies
and transmission of sexually transmitted infections (STIs)
[11]. However, contraceptive methods vary in their effect-
iveness during routine use (i.e., including both incorrect
and inconsistent use) and during perfect use (correct and
consistent use) [12]. In PLHIV, the concurrent use of
hormonal contraceptives and antiretroviral medications
(the non-nucleoside reverse transcriptase inhibitors and
protease inhibitors) can be associated with drug-drug
interactions that may alter the contraceptive or antiretro-
viral effects of these medications [13]. In addition, contra-
ceptives that are most effective at preventing pregnancy
under routine use (e.g, hormonal contraceptives) provide
no protection against HIV/STIs. Though condoms can
prevent transmission of HIV and other STIs [5], inconsist-
ent and incorrect condom use is common [12]. Studies
report 14 to 21 % of people who use condoms alone be-
come pregnant during the first year of routine condom
use [12, 14]. As a result, the World Health Organization
(WHO) recommends that PLHIV use dual contraceptive
methods or dual protection to prevent unintended preg-
nancies and STIs [15]. Dual contraceptive method use is
defined as the use of a barrier contraceptive (i.e.,
condoms), which can reduce transmission of many STIs,
plus another effective family planning method that can
prevent pregnancy as recommended by the World Health
Organization (e.g., sterilization, hormonal methods, intra-
uterine devices, hormonal pills) [16, 17]. There are limited
data on dual contraceptive use and the intention to be-
come pregnant among PLHIV in Thailand. We assessed
the intention of PLHIV to become pregnant and have chil-
dren in the future and their use of dual contraceptive
methods at six hospitals in Thailand.
Methods
Study population and procedures
From January 2008 to December 2009, every sixth PLHIV
seeking care at HIV or Obstetrics and Gynecology (OB/
GYN) clinics at four tertiary care hospitals in Bangkok,
one in Nonthaburi, and one community hospital in
Chiang Rai Province was offered enrollment in this cohort
study. These hospitals were participating in the implemen-
tation and evaluation of a ‘prevention with positives
(PwP)’ model. Information about the model has been pre-
sented elsewhere [18, 19]. The PwP model includes six
prevention strategies: sexual and behavioral risk reduction,
STI screening and treatment for PLHIV and their partners,
promotion of HIV disclosure to partners, promotion of
partner HIV testing, ARV treatment and adherence, and
family planning and prevention of mother-to-child HIV
transmission services. Health care providers including doc-
tors, nurses, and counselors at the six hospitals were
trained to deliver the PwP service model as part of routine
service to all PLHIV attending the clinics. They provided
the brief prevention messages [20] to all clinic at-
tendees incorporating specific HIV prevention mes-
sages, based on needs of PLHIV at every clinical visit
(usually every 3 months).
In this study, we focused on the family planning strat-
egy among PLHIV and their steady partners. A steady
partner was defined as someone with whom the PLHIV
had an emotional (e.g., loving, caring, respectful) and
sexual relationship lasting at least 2 months. Assessment
of pregnancy intention and needs for family planning,
contraceptives, and short messages are shown in Fig. 1.
PLHIV who requested family planning counseling or
contraceptive service were referred for additional, more
specific participant-centered family planning counseling
or contraceptive service which were provided during
routine clinical visits or, if necessary, scheduled for a
date that was convenient for the health care worker and
the PLHIV. The project hired a fulltime staff person for
each of the two tertiary care hospitals (i.e., Siriraj and
Rajavithi Hospitals) because there were insufficient staff
at the two hospitals to complete study activities. The
other hospitals were able to implement the PwP service
model using existing staff.
Trained counselors provided PLHIV who were offered
enrollment a brief description of study activities and
PLHIV who wished to participate completed the infor-
med consent process. PLHIV who wanted to enroll,
signed the consent form. If a PLHIV did not want to
participate, the next PLHIV presenting for care was
offered the assessment. A trained counselor or nurse
interviewed enrolled participants using a standardized
questionnaire at baseline, and every 3 months for 4
visits (12 months ± 3 months) during a routine clinic
visit to gather demographic data and information
about their sexual activity and practices, disclosure of
their HIV status to their partner, their partner’s HIV
status, their partner’s and their intention to become
pregnant in the future, and contraception practice during
the previous 3 months. Contraceptive methods available to
participants in the study included oral pills, hormonal in-
jections, hormonal implants, male and female sterilization,
condoms, and intrauterine devices. PLHIV received short
family planning messages based on Thailand Ministry of
Public Health (MOPH) Prevention with Positives Guide-
lines [20] (Fig. 1).
Counseling on sexual risk reduction, HIV disclosure,
and ART adherence was provided as part of routine HIV
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care in the clinics and condoms were provided free of
charge. PLHIV in this study were provided CD4 cell
count and viral load (VL) testing free of charge by the
National AIDS Program and ART if eligible according to
Thai National Guidelines 2007 [21]. We abstracted CD4
cell count and VL test results (within 6 months) from
patient medical records for analysis.
Data analysis
Female PLHIV aged 18-49 years and males aged 18 years
and older were selected for analysis at baseline. PLHIV
who completed at least 4 visits including a visit at least
12 months after the baseline visit were included in the ana-
lysis. Data were analyzed and statistical tests performed
using SAS 9.3 (SAS Institute Inc., North Carolina, USA).
Fig. 1 Pregnancy desire assessment and family planning short messages
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Pearson chi-squared and Fisher’s exact tests were used to
test for differences in proportions. We used logistic re-
gression to calculate the odds ratios (OR) of factors associ-
ated with using dual contraceptive methods at baseline
and log-binomial regression to test for factors associated
with changing from a single contraceptive method at base-
line to dual methods at 12 months. Factors associated with
changing to dual contraceptive methods in bivariate
analysis (p-values <0.1) were included in a multivariable
model. The analyses did not account for intra-cluster cor-
relations by site since the sites were purposively selected
from the six hospitals implementing PwP services. The
effect of selecting groups of clients from clusters (i.e., hos-
pitals) who may be similar in various aspects should be
small in this study because clients were systematically
sampled (every sixth PLHIV who visited the clinic) for
assessment.
Ethics approval
The study protocol, consents, and questionnaires were
reviewed and approved by the Thailand MOPH Ethical
Review Committee (ERC), Bangkok Metropolitan Admin-
istration (BMA) ERC, Siriraj Hospital ERC, and the U.S.




From January 2008 to March 2009, 1,570 HIV-infected
heterosexual men and women were recruited for the
study. We excluded 137 women because they were preg-
nant and 45 female PLHIV who were 50 years or older
from the analysis. Of the 1,388 PLHIV selected for data
analysis, 737 (53.1 %) were male, their median age was
37 years (Interquartile range [IQR] 33–43 years) and 776
(55.9 %) were married or living with their partner. Par-
ticipants had known their HIV status a median of 5 years
(IQR 2–8 years). Most PLHIV (99.7 %) were taking ART
and their median CD4 count was 343 (IQR 201–502)
cells/mm3 and, among the 719 (51.8 %) who had viral
load results, median viral load was <50 (IQR 40–50)
copies/mL. Participant demographics characteristics are
shown in Table 1.
Of the 1,388 PLHIV who participated in the interview
at baseline, 966 (69.6 %) participated in the interview at
12 months (4th visit). Among the 422 PLHIV who did
not participate in the interview at 12 months, 324
(76.8 %) were not interviewed because hospital staff were
not available to conduct the interview according to the
project schedule and 98 (23.2 %) declined to participate
in the interview or were lost to follow-up for more than
180 days after an appointment.
HIV disclosure to partner, partner HIV status, and
pregnancy intent
At enrollment, 898 (64.7 %) PLHIV had a steady partner,
765 (85.2 %) had disclosed their HIV status to their part-
ner, and 105 (34.7 %) of partners were HIV-infected.
Among the 898 participants who had a steady partner,
36 (4.0 %) reported they intended to become pregnant in
the future. Excluding PLHIV and partners who had been
sterilized, 34 (6.1 %) reported they intended to become
pregnant in the future.
Current contraceptive practices
Among 709 PLHIV who had no intention to become
pregnant in the future and reported having sex during
the previous 3 months, 683 (96.3 %) reported using at
least one contraceptive method during the previous
3 months (Table 1). Only 202 (29.6 %) reported using
two or more contraceptive methods (dual methods) and,
in this group, 141 (69.8 %) used male or female
sterilization and condoms. None of PLHIV in this study
reported using intrauterine devices. Contraceptive
methods used by participants are shown in Table 1.
Changes in pregnancy intention and sexual behavior after
receiving family planning short messages
Of the 898 PLHIV who had a partner, 623 (69.4 %)
PLHIV came for follow-up at 12 months. Of these, 29
(4.7 %) reported at baseline that they intended to be-
come pregnant, but 25 (86.2 %) changed their minds and
reported they did not plan to have children at the
12 month visit. Only three of the 862 (0.3 %) PLHIV
who did not plan to have children at baseline changed
their minds and reported that they planned to become
pregnant in the future at the 12 month visit. None of the
PLHIV or their partners was pregnant at 12 months.
Factors associated with dual contraceptive use at baseline
Factors associated with dual contraceptive use during
the previous 3 months before baseline in multivariable
analysis, included being female (adjusted Odds Ratio
[aOR] 1.4; 95 % confidence interval [CI] 1.02–2.1), re-
ceiving care at Viangpapao Hospital (aOR 2.6; 95 % CI
1.3–5.0) or Rajavithi Hospital (aOR 2.6; 95 % CI 1.2–
5.2), and being aware of their HIV status for 1 to 5 years
(aOR 2.5; 95 % CI 1.1–5.5) or more than 5 years (aOR
2.6; 95 % CI 1.2–5.6) (Table 2).
Factors associated with changing from a single
contraceptive method at baseline to dual methods at
12 months
Of the 481 participants who reported using a single
method of contraception during the previous 3 months
at baseline, 317 (65.9 %) were re-interviewed 12 months
later and 66 (20.8 %) had changed to use dual
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Table 1 Baseline characteristics of participants in the assessment of family planning practices at 6 hospitals in Thailand, 2008-2009
Characteristics Total (N = 1,388) Male (n = 737; 53.1 %) Female (n = 651; 46.9 %)
No. (%) No. (%) No. (%)
Hospital
Vajira (BKK) 202 (14.6) 102 (13.8) 100 (15.4)
Taksin (BKK) 165 (11.9) 99 (13.4) 66 (10.1)
Rajavithi (BKK) 93 (6.7) 29 (3.9) 64 (9.8)
Siriraj (BKK) 250 (18.0) 110 (14.9) 140 (21.5)
Bamrasnaradura Infectious Diseases Institute (Nonthaburi) 588 (42.4) 343 (46.5) 245 (37.6)
Viangpapao (Chiang Rai) 90 (6.5) 54 (7.3) 36 (5.5)
Age
Median age in years (IQR) 37 (33, 43) 39 (34, 45) 35 (32, 40)
18–29 years old 164 (11.8) 69 (9.4) 95 (14.6)
30–39 years old 677 (48.8) 310 (42.1) 367 (56.4)
40–49 years old 447 (32.2) 258 (35.0) 189 (29.0)
> 50 years old 100 (7.2) 100 (13.6) 0 (0.0)
Education group
≤ Primary school 533 (38.4) 257 (34.9) 276 (42.4)
> Primary school 853 (61.5) 478 (64.9) 375 (57.6)
Missing 2 (0.1) 2 (0.3) 0 (0.0)
Marital status
Single 301 (21.7) 253 (34.3) 48 (7.4)
Married with and/or Live in partner 776 (55.9) 372 (50.5) 404 (62.1)
Divorced or Separated 311 (22.4) 112 (15.2) 199 (30.5)
Years since HIV diagnosis
Median (IQR) 5 (2, 8) 5 (2, 7) 5 (2, 9)
< 1 year 120 (8.7) 61 (8.4) 59 (9.1)
1 to less than 5 years 529 (38.5) 298 (40.9) 231 (35.8)
≥ 5 years 726 (52.8) 370 (50.8) 356 (55.1)
Missing 13 8 5
On ART
Yes 1,157 (99.7) 649 (99.7) 508 (99.8)
No 3 (0.3) 2 (0.3) 1 (0.2)
Missing 228 86 142
CD4 count at baselinea
Median (IQR) cells/mmb 343 (201–502) 326 (181–475) 376 (225–530)
Viral loadc
Median (IQR) copies/mL 50 (40–50) 50 (40–50) 50 (40–50)
Received short messages relating to family planning at enrollment
(PLHIV may receive messages from many staff)
From doctor 927 (66.8) 514 (69.7) 413 (63.4)
From nurse 455 (32.8) 258 (35.0) 197 (30.3)
From counselor 1,042 (75.1) 571 (77.5) 471 (72.4)
Have steady partner
No 490 (35.3) 290 (39.3) 200 (30.7)
Yes 898 (64.7) 447 (60.7) 451 (69.3)
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contraceptive methods. In the multivariable analysis,
participants receiving care in Rajavithi (p = 0.03) and
Siriraj (p = 0.02) Hospitals were more likely to change
to dual methods than participants receiving care at the
other sites (Table 3).
Discussion
Most (96.3 %) PLHIV who reported having sex with
their steady partner in our study used at least one
contraceptive method but less than one-third used dual
methods. The most common single method used was
condoms (87.7 %). Because of inconsistent and incorrect
condom use, condom use alone is associated with preg-
nancy rates as high as 18 % [15]. Therefore, dual con-
traceptive protection is strongly recommended to protect
against HIV/AIDS and other STIs [13]. WHO urges
healthcare providers to educate PLHIV on the benefits of
dual protection use and to provide PLHIV access to
contraceptives.
In this study, the most common combination of con-
traceptives used was condoms and sterilization (69.8 %).
Our analyses indicate that female PLHIV and PLHIV
Table 1 Baseline characteristics of participants in the assessment of family planning practices at 6 hospitals in Thailand, 2008-2009
(Continued)
Among PLHIV with steady partner (n = 898)
Intention to become pregnant in the future
Yes 36 (4.0) 13 (2.9) 23 (5.1)
No 862 (96.0) 434 (97.1) 428 (94.9)
Disclosed HIV status to steady partner 765 (85.2) 385 (86.1) 380 (84.3)
Steady partner HIV status
Positive 385 (42.9) 183 (40.9) 201 (44.6)
Negative 288 (32.1) 161 (36.0) 127 (28.2)
Unknown 225 (25.1) 103 (23.0) 123 (27.3)
Among PLHIV with steady partner who had sex during the previous
3 months and had not had sterilization (n = 558)
558 291 267
Intention to become pregnant in the future
Yes 34 (6.1) 13 (4.5) 21 (7.9)
No 524 (93.9) 278 (95.5) 246 (92.1)
Among 862 PLHIV not planning to become pregnant in the future
Had sex during the previous 3 months 709 (82.3) 352 (81.1) 357 (83.4)
Contraceptive used during the past 3 monthsb 683 (96.3) 341 (96.9) 342 (95.8)
If contraceptive used (n = 683), methods used
Single method used 481 (70.4) 257 (75.4) 224 (65.5)
Oral pills 12 (2.5) 4 (1.6) 8 (3.6)
Hormonal injection 4 (0.8) 0 (0.0) 4 (1.8)
Hormonal implantation 6 (1.2) 0 (0.0) 6 (1.2)
Sterilization 37 (7.7) 10 (3.9) 27 (12.0)
Condom 422 (87.7) 243 (94.6) 179 (79.9)
Intrauterine device 0 (0.0) 0 (0.0) 0 (0.0)
Two or more methods usedd 202 (29.6) 84 (24.5) 118 (34.2)
Condom and sterilization 141 (69.8) 63 (75.0) 78 (66.1)
Condom and oral pills 36 (17.8) 13 (15.5) 23 (19.5)
Condom and hormonal implantation 16 (7.9) 3 (3.6) 16 (13.6)
Condom and hormonal injection 10 (5.0) 5 (6.0) 5 (4.2)
Condom and oral pills and hormonal injection 1 (0.5) 0 (0.0) 1 (0.8)
aNumber of participants with CD4 count data = 1,200 persons
bSelf or partner
cNumber of participants with viral load data = 719 persons
dPill/hormonal injection/hormonal implantation/male or female sterilization/condom/intrauterine device
Numbers might not sum to 100 % due to rounding
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who were aware of their HIV status for more than one
year were more likely to use dual methods. This may be
because PLHIV who were aware of their HIV status for
more than one year were more likely to have received
family planning messages and referral services as part of
HIV service package. Women reported dual contraceptive
Table 2 Factors associated with dual contraceptive use at baseline among PLHIV in the assessment of family planning practices at
6 hospitals in Thailand, 2008 − 2009
Characteristics Use of dual methods (n = 683) OR (95 % CI) p-value Adjusted OR
(95 % CI)
p-value
Yes (n = 202) No (n = 481)
No. (%) No. (%)
Sex
Female 118 (34.5) 224 (65.5) 1.6 (1.1–2.2) <0.01 1.4 (1.02–2.1) 0.04
Male 84 (24.6) 257 (75.4) 1.0 1.0
Age
< 29 years 24 (24.5) 74 (75.5) 0.7 (0.3–1.8) 0.66
30–39 years 110 (31.3) 241 (68.7) 1.0 (0.5–2.3) 0.94
40–49 years 58 (28.9) 143 (71.1) 0.9 (0.4–2.1) 0.97
> =50 years 10 (30.3) 23 (69.7) 1.0
Educationa
< =Primary school 82 (31.1) 182 (68.9) 1.1 (0.8–1.6) 0.57
> Primary school 120 (28.7) 298 (71.3) 1.0
Marital status
Single 2 (3.8) 51 (96.2) 0.3 (0.1–1.7) 0.17 0.3 (0.1–1.9) 0.22
Married/Live in partner 196 (32.9) 400 (67.1) 3.7 (1.3–10.6) 0.02 2.7 (0.9–8.2) 0.08
Divorce/Separated 4 (11.8) 30 (88.2) 1.0 1.0
Time since HIV diagnosisa
≥ 5 years 103 (30.5) 235 (69.5) 2.4 (1.2–4.9) 0.01 2.6 (1.2–5.6) 0.02
1 to less than 5 years 86 (31.3) 189 (68.7) 2.5 (1.2–5.1) 0.01 2.5 (1.1–5.5) 0.02
< 1 year 10 (15.4) 55 (84.6) 1.0 1.0
Disclosure of HIV status to steady partner
Yes 190 (31.8) 407 (68.2) 2.9 (1.5–5.4) <0.01 1.7 (0.8–1.7) 0.14
No / No partner 12 (13.9) 74 (86.0) 1.0 1.0
Steady partner HIV status
Positive 105 (34.6) 198 (65.4) 1.5 (1.1–2.1) 0.01 1.2 (0.8–3.4) 0.32
Negative/unknown 97 (25.5) 283 (74.5) 1.0 1.0
Hospital
Viangpapao 22 (51.2) 21 (48.8) 3.5 (1.8–6.8) <0.01 2.6 (1.3–5.0) <0.01
Rajvithi 22 (43.1) 29 (56.9) 2.5 (1.4–4.7) <0.01 2.6 (1.2–5.2) 0.01
Siriraj 29 (24.6) 89 (75.4) 1.1 (0.7–1.8) 0.72 0.8 (0.5–1.4) 0.55
BMA (Vajira&Taksin) 59 (35.5) 107 (64.5) 1.8 (1.2–2.8) <0.01 1.5 (1.0–2.3) 0.08
Bamrasnaradura 70 (23.0) 235 (77.0) 1.0 1.0
CD4a
< 200 43 (33.1) 87 (66.9) 1.2 (0.8–1.8) 0.43
> =200 133 (29.0) 326 (71.0) 1.0
Ever received ART
Yes 169 (30.9) 378 (69.1) 1.4 (0.9–2.1) 0.16
Never 33 (24.3) 103 (75.7) 1.0
Numbers might not sum to 100 % due to rounding
aNumber may not equal to 683 due to missing value
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Table 3 Factors associated with changing from a single method of contraception at baseline to dual methods 12 months later
among participants in the assessment of family planning practices at 6 hospitals in Thailand, 2008–2009
Characteristics Use of dual methods at 12 months (n = 317) RR (95 % CI) p-value Adjusted RR
(95 % CI)
p-value
Yes (n = 66) No (n = 251)
Sexa (no.,%)
Female 36 (19.0) 154 (81.0) 1.2 (0.8–1.9) 0.37
Male 30 (23.8) 96 (76.2) 1.0
Age (no.,%)
< 29 years 12 (24.0) 38 (76.0) 1.1 (0.4–3.4) 0.87
30–39 years 30 (18.7) 130 (81.3) 0.9 (0.3–2.5) 0.91
40–49 years 21 (22.6) 72 (77.4) 1.0 (0.4–3.1) 0.80
> =50 years 3 (21.4) 11 (78.6) 1.0
Educationa (no.,%)
< =Primary school 28 (20.6) 108 (79.4) 1.0 (0.6–1.5) 1.0
> Primary school 38 (21.2) 141 (78.8) 1.0
Marital status (no.,%)
Single 0 (0.0) 27 (100.0) N/A 0.34
Married/Live in partner 65 (23.5) 211 (76.5) 3.3 (0.5–22.0) 0.20
Divorce/Separated 1 (7.1) 13 (92.9) 1.0
Disclosure of HIV status to steady partner (no.,%)
Yes 55 (20.2) 217 (79.8) 0.8 (0.5–1.4) 0.65
No / No partner 11 (24.4) 34 (75.6) 1.0
Steady partner HIV status (no.,%)
Positive 29 (20.6) 112 (79.4) 1.0 (0.6–1.5) 1.0
Negative/unknown 37 (21.0) 139 (79.0) 1.0
Hospital (no.,%)
Viangpapao 4 (20.0) 16 (80.0) 1.5 (0.5–4.3) 0.48 1.5 (0.5–4.3) 0.43
Rajvithi 11 (47.8) 12 (52.2) 3.7 (1.9–7.2) <0.001 2.5 (1.1–5.7) 0.03
Siriraj 26 (32.1) 55 (67.9) 2.5 (1.3–4.5) <0.01 2.2 (1.1–4.2) 0.02
BMA (Vajira&Taksin) 13 (12.9) 88 (87.1) 1.0 (0.5–2.0) 1.0 1.0 (0.5–2.1) 0.98
Bamrasnaradura 12 (13.0) 80 (87.0) 1.0 1.0
Time since HIV diagnosis at enrollmenta (no.,%)
≥ 5 years 25 (16.9) 123 (83.1) 0.4 (0.2–0.8) 0.01 0.5 (0.2–1.0) 0.051
1–4 years 28 (20.4) 109 (79.6) 0.5 (0.3–0.9) 0.05 0.6 (0.3–1.1) 0.12
< 1 year 12 (38.7) 19 (61.3) 1.0 1.0
CD4a (no.,%)
< 200 7 (20.6) 27 (79.4) 1.0 (0.5–2.1) 0.10
> =200 54 (19.8) 219 (80.2) 1.0
Ever received ARVa (no.,%)
Yes 45 (17.2) 217 (82.8) 0.5 (0.3–0.7) <0.01 0.8 (0.4–1.6) 0.61
No 20 (37.0) 34 (63.0) 1.0 1.0
Received short messages relating to family planning from nurse at enrollment (no.,%)
No 25 (28.7) 62 (71.3) 1.6 (1.0–2.5) .05 1.5 (0.9–2.4) 0.15
Yes 41 (17.8) 189 (82.2) 1.0 1.0
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use more frequently than men (p = 0.04). Women can in-
dependently initiate contraceptive choices, while men are
not always aware of the partner’s contraceptive method
and may not be aware of all contraceptives used (e.g., their
partners’ oral or hormonal contraceptive use). A study in
Chiang Mai, a Northern province of Thailand [22],
showed that the rate of contraceptive use in postpartum
HIV-uninfected women was high (97.6 %) and most used
modern contraceptive methods; males reported condom
use only 7.7 % of the time [22]. In contrast, a study of
HIV-infected women in Chiang Mai found that 87 % of
their partners used condoms [17, 23–25] and 18–56 % of
the women used dual contraceptive methods; consistent
with the findings of our study. Studies from India and
Zambia have also reported that condoms and sterilization
were the most common dual methods used among PLHIV
in those countries [24, 25].
Studies have shown that integration of family planning
services into HIV care is feasible and increases the use
of contraceptives among HIV-infected women, and
improves a variety of health and behavioral outcomes
[12, 26]. In our study, the use of dual contraceptive
methods varied by site (e.g., rate of dual methods was
higher in Viengpapao Hospital and Rajavithi Hospital
than Siriraj Hospital, Vajira Hospital, Taksin Hospital,
and Bamrasnaradura Infectious Diseases Institute). None
of the six sites provided one stop service of family plan-
ning service and HIV care. After we implemented short
messages on family planning and referral services, one-
fifth (20.8 %) of PLHIV who did not use dual contracep-
tive methods at baseline changed to dual methods at
12 months. This was particularly clear at Rajavithi and
Siriraj Hospital, where there were project coordinators
who helped facilitate referrals and link PLHIV to family
planning services, whereas other hospitals implemented
the services using routine staff and the routine referral
system. Many HIV clinics in Thailand do not integrate
family planning services with HIV care as a one stop
service. Thus, having a staff person or a case manager
who helps facilitate referrals and link PLHIV to family
planning services can increase the likelihood PLHIV
will access family planning services. Additional research
on models that integrate family planning services in HIV
clinics providing a one stop service would be helpful.
More than 80 % of reproductive age PLHIV who had a
steady partner in our study reported having sex, but few
(4.0 %) expressed a desire to have children. In contrast
to studies in Europe and North America that report high
fertility desire (69–75 %) and fertility intention (58 %)
among reproductive age HIV-infected women [4, 26],
our study found that only three HIV-infected women
(0.3 %) who initially said they did not intend to become
pregnant in the future because of their HIV diagnosis,
changed their minds at 12 months. PLHIV in our study
may not intend to become pregnant because more than
half had not disclosed their HIV status to their partners
and they may be concerned about discussing pregnancy
and family planning with their partners. Furthermore,
half of female PLHIV in our study were older than
35 years and may not want to become pregnant [27].
Other potential concerns among health care providers
and PLHIV in Thailand include that PLHIV may transmit
HIV to their infants, the misperception that HIV is an
untreatable disease, and social discrimination that often
occurs when others learn that one is infected [28, 29].
With access to ART free of charge under the Thai
National HIV Treatment Program, HIV has become a
manageable chronic disease. The Thailand National Pre-
vention of Mother-to-Child HIV Transmission (PMTCT)
Policy 2010 recommended using a lopinavir/ritonavir-
based regimen for PMTCT [30] and the MTCT rate in
Thailand was 2.3 % in 2012 [1]. Current evidence-based
information and education should be provided to PLHIV
and health care providers to help reduce stigma and
discrimination.
The Thailand National HIV Treatment and Care Guide-
lines 2014 recommend that health care providers discuss
pregnancy and childbearing intentions with all PLHIV, rec-
ommend effective and appropriate contraceptive methods
(dual methods) to reduce the likelihood of unintended
pregnancy and STI, provide reproductive options for
HIV-concordant and serodiscordant couples who want
Table 3 Factors associated with changing from a single method of contraception at baseline to dual methods 12 months later
among participants in the assessment of family planning practices at 6 hospitals in Thailand, 2008–2009 (Continued)
Received short messages relating to family planning from doctor at enrollment (no.,%)
No 41 (21.8) 147 (78.2) 1.1 (0.7–1.7) 0.70
Yes 25 (19.4) 104 (80.6) 1.0
Received short messages relating to family planning from counselor at enrollment (no.,%)
No 42 (21.2) 156 (78.8) 1.0 (0.7–1.6) 0.94
Yes 24 (20.2) 95 (79.8) 1.0
Numbers might not sum to 100 % due to rounding
RR relative risk, CI confidence interval
aNumber may not equal to 317 due to missing values
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to conceive (e.g., provide ART to the HIV-infected
partner to have maximum viral suppression before
attempting conception, provide assisted reproductive
technology options, and consider administration of
antiretroviral pre-exposure prophylaxis [PrEP] for HIV-
uninfected partners) [31].
Our study had several limitations. Data were limited to
PLHIV seen at five tertiary care hospitals in Bangkok,
and one community hospital in the Chiang Rai province
and PLHIV were on ART for average of 5 years; there-
fore, the results may not be generalizable to other set-
tings in Thailand, to PLHIV who are not on ART, or to
PLHIV who do not access to HIV prevention messages.
Assessment of contraceptive methods used by men was
challenging because some did not know their partners
contraceptive method, resulting in an underestimate of
contraception use in this study. Similarly, assessment of
the intention to become pregnant of partners, particu-
larly those who did not disclosed their HIV status, might
be inaccurate. This model was implemented and inte-
grated into routine hospital service during our evaluation,
likely contributing to the 30 % of the PLHIV who did not
participate in the interview at 12 months. This may have
led to over or under estimates of some of the findings.
About half of female PLHIV in our study were older than
35 years. Hence, the data in this survey may not accurately
reflect the pregnancy intentions of younger reproductive
age female PLHIV.
Conclusion
In conclusion, less than one-third of PLHIV and their
partners who did not intend to become pregnant used
dual contraceptive methods. These findings highlight the
need for assessing contraceptive methods used among
PLHIV and their partners in routine clinical service. Our
study showed that having a coordinator who can facili-
tate referral and link PLHIV to family planning services
is important. In order to promote joint decision-making
among couples for family planning, HIV disclosure to
partners should be promoted. Future studies are needed
to assessment pregnancy desire and intent and con-
traceptive use among young PLHIV. This is particularly
important in Thailand as the treatment for all regardless
of CD4 count policy [31] and getting to zero stigma and
discrimination policy [32] are implemented, which will
likely be associated with better treatment outcome and
longer healthier lives for PLHIV. Other interventions
that can help increase the use of dual contraceptive
methods among PLHIV and their partners should be
explored.
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